Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling
Authors:
- Christopher T. CottageCCChristopher T. Cottage
- Mathias H. KonstandinMKMathias H. Konstandin
- Mirko VölkersMVMirko Völkers
- Mohsin KhanMKMohsin Khan
- Mark A. SussmanMSMark A. Sussman
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 51 (4) , 554-558
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25CThe International Journal of Biochemistry & Cell Biology, 2006
- The survival kinases Akt and Pim as potential pharmacological targetsJournal of Clinical Investigation, 2005
- The serine/threonine kinase Pim-1The International Journal of Biochemistry & Cell Biology, 2005
- Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 KinaseJournal of Biological Chemistry, 2005
- The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathwayOncogene, 1999
- Physical and Functional Interactions between Pim-1 Kinase and Cdc25A PhosphataseJournal of Biological Chemistry, 1999
- Evidence implicating Gfi‐1 and Pim‐1 in pre‐T‐cell differentiation steps associated with β‐selectionThe EMBO Journal, 1998
- Identification of the Autophosphorylation Sites of theXenopus laevis Pim-1 Proto-oncogene-encoded Protein KinaseJournal of Biological Chemistry, 1997
- The human PIM-1 gene product is a protein serine kinase.1991
- The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.Proceedings of the National Academy of Sciences, 1989